Uric acid to albumin ratio for predicting kidney injury after contrast procedures
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at whether the ratio of uric acid to albumin in your blood before a procedure that uses contrast dye can help predict if you might develop kidney damage afterward. It aims to find a simple way to identify patients at higher risk so they can be monitored more closely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You are scheduled to have a procedure that uses contrast dye (for example, a heart catheterization or other imaging test).
- You must have a blood test before the procedure to measure your kidney function, uric acid, and albumin levels.
- You do not have severe kidney disease or be on dialysis.
- You have not had a contrast procedure within the last 7 to 10 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether the amount of contrast dye used in a CT scan can predict kidney injury. It will follow your kidney function with a blood test after your scan, which may help identify patients at risk of kidney problems.
This study tests if a simple blood test (cystatin) can detect kidney damage earlier in people with chronic kidney disease who receive contrast dye for imaging. It could help doctors act faster to protect kidneys.
This study tests a new light-based method to check kidney function right after heart surgery or imaging tests that use contrast dye. It aims to catch kidney damage early, so doctors can treat it sooner.
This study looks at whether changes in blood electrolyte levels (like sodium and potassium) after stroke treatment can predict kidney damage caused by the contrast dye used during the procedure. If you've had endovascular treatment for an ischemic stroke, your data might help improve care for future patients.
This trial tests whether using a much smaller amount of contrast dye for an invasive heart scan is safer for people with acute kidney injury (AKI). It may help reduce further kidney stress while still allowing doctors to look at coronary (heart) arteries.
This trial tests if drinking beetroot juice can help protect your kidneys from damage caused by the dye used during heart procedures. It is for people hospitalized with a certain type of heart attack who are at moderate to high risk of kidney problems.
Hear when a new Contrast-induced Nephropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.